Mitochondrial DNA repair enzyme OGG1 is essential for protection against the downregulation of chondrocyte activity in OA  by Yudoh, K. et al.
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S114Analysis of BMP-2 signaling under hypoxia showed an unexpected inhi-
bition of Smad1/5/8 phosphorylation, whereas p38MAPKwas activated.
Inhibition of p38MAPKwith SB202190 prevented Sox9 binding onto the
type II collagen promoter and subsequent type II collagen production.
Conclusions: in addition to the HIF pathway, hypoxia could help to
promote the chondrocyte phenotype through p38 MAPK signaling.
These results suggest that hypoxia environment could be a not only an
anabolic signal per se, but also a physiological signal that boosts the
action of anabolic growth factors on the resident chondrocytes in
human cartilage. Thus, combination of hypoxia and BMP-2 could be
considered for a better control of the chondrocyte phenotype during the
ampliﬁcation step used in the cell therapy protocols such as Autologous
Chondrocyte Implantation.201
HYPERCHOLESTEROLEMIA AND LIPID ACCUMULATION IN
CHONDROCYTES
K. Kuroki, C. Bozynski, A. Stoker, M.H. Laughlin, J.L. Cook. Univ. of
Missouri Columbia, Columbia, MO, USA
Purpose: Patients with primary OA commonly have cardiovascular
disease (CVD) and it has been reported that cardiovascular mortality is
directly proportional to the extent of OA in affected individuals.
Although the high incidence of concurrent OA and CVD may be merely
an independent feature of advanced age and/or obesity (major risk
factors for both), one can speculate that there is a direct link between
the two. In an attempt to investigate the effects of hypercholesterolemia
and exercise on lipid accumulation in chondrocytes, we examined
articular cartilage from hypercholesterolemic pigs. Our hypotheses
were that lipid accumulation in chondrocytes would be elevated in
hypercholesterolemic pigs and lipid accumulation in chondrocytes
would be altered by exercise.
Methods: All procedures were approved by the institution's animal
care and use committee. Familial hypercholesterolemic pigs (FMH,
n¼6) were randomized to either a sedentary (Sed, n ¼ 3) or exercise
(Ex, n ¼ 3) group. The Ex group was trained between 20 and 24
months of age using an established progressive treadmill-based
training program. The Sed group was caged alongside the Ex animals
but did not undergo training. Blood and medial femoral condyles were
obtained after euthanasia at 24 months of age. Articular cartilage was
obtained from the weight bearing portion of the medial femoral
condyle of the left knee for quantiﬁcation of glycosaminoglycan (GAG)
content using DMMB assay. Medial femoral condyles of the right knees
were ﬁxed in 10% neutral buffered formalin ﬁxative, decalciﬁed in 10%
EDTA solution, cryosectioned, and stained with oil red O for exami-
nation of lipid accumulation. The remaining right medial femoral
condyles were routinely processed, sectioned and stained with H&E
and Toluidine blue for histopathologic examination. Blood and medial
femoral condyles obtained from size matched regular crossbred pigs
served as a normocholesterolemic control (n¼3). Three consecutive
images of mid-central articular cartilage of each section were captured
using a microscope with a 40x objective lens and a digital camera. The
number of lipid particles, the total area of lipids, and the number of
chondrocytes were quantiﬁed using the computer software Image-Pro
Plus, ver. 7 (Media Cybermetrics, Inc. Bethesda, MD). Data from each
group were combined and mean  S.D. determined. Signiﬁcance was
set at p < 0.05.
Results: Total cholesterol and low-density lipoprotein in FMH (both Ex
and Sed) were signiﬁcantly higher than in controls (P<0.005). None of
the plasma lipid indices were altered between Ex and Sed. The number
of lipid particles per 100 chondrocytes was signiﬁcantly higher in the
Sed (15.9  6.9) and Ex (7.9  2.6) compared to controls (4.6  3.1)
(P<0.005). While total lipid area was largest in Sed, followed by Ex and
controls, there were no statistical differences between the groups
(P¼0.096). GAG content [mg/dry weight (mg)] was signiﬁcantly higher
in the controls (216.8  19.2) compared to Ex (126.4  18.2) and Sed
(129.5  23.2). There was not a statistically signiﬁcant difference
between Ex and Sed for GAG concentration. Subjectively, the articular
cartilage of the FMH groups had reduced toluidine blue staining
compared to controls.
Conclusions: Loss of GAG, which is often the earliest histology ﬁnding
associated with osteoarthritis, was evident in FMH pigs. This study also
demonstrated increased chondrocyte lipid accumulation in hypercho-
lesterolemic animals providing further evidence for a potential link
between cardiovascular disease and osteoarthritis. Exercise may beassociated with beneﬁts to chondrocyte lipid metabolism at the cellular
level, however, further research is necessary to delineate these ﬁndings.202
ABERRANT EXPRESSION OF AUTOPHAGY MARKERS DURING
OSTEOARTHRITIS
Y. Zhang, F. Vasheghani, M. Blati, J. Martel-Pelletier, J. Pelletier,
M. Kapoor. Univ. of Montreal, Montreal, QC, Canada
Objectives: Recent studies suggest that the process of autophagy,
a form of programmed cell survival, is impaired during osteoarthritis
(OA) and may contribute towards decreased chondroprotection in
the articular cartilage associated with OA pathophysiology. To
further explore the role of autophagy in OA, we determined the
expression of known autophagy genes in human OA, mouse and dog
model of OA.
Methods: Human normal and OA cartilage was subjected to human
autophagy PCR array and Heatmap was generated. The expression of
key autophagy markers was further investigated by quantitative PCR
(qPCR) and immunohistochemistry and compared with mouse and dog
OA model. The effect of major OA pro-inﬂammatory cytokine (IL-1b) on
the expression of autophagy markers was also determined.
Results: The Heatmap and GEDI images obtained from human auto-
phagy PCR array demonstrated a down-regulation of 16 and up-regu-
lation of 17 autophagy genes in human OA cartilage versus normal
cartilage, with a fold change of <-1.5 or >1.5 respectively. Data further
demonstrated a signiﬁcant up-regulation in the expression of auto-
phagy master regulator mTOR, and signiﬁcant reduction in the
expression of key autophagy markers including ULK1 (most up stream
autophagy inducer), LC3B (critical factor for autophagy vacuole
formation), ATG5 (required for autophagosome formation) and BNIP3
(interactor of LC3) in human OA compared to normal cartilage. Simi-
larly, a signiﬁcant up-regulation in the expression of mTOR and
downregulation of autophagy-speciﬁc genes (LC3B and ATG5) was
observed in mouse and dog experimental OA. Treatment of normal
human cartilage explants with IL-1b resulted in a signiﬁcant reduction
in the expression of LC3B, ATG5 and BNIP3.
Conclusions: This study is the ﬁrst to provides a global view of dysre-
gulation in the expression of mTOR and various autophagy-speciﬁc
genes in human OA compared to experimentally-induced OA in mouse
and dogs. Targeting autophagy could open up new therapeutic avenues
for OA treatment or prevention.203
MITOCHONDRIAL DNA REPAIR ENZYME OGG1 IS ESSENTIAL FOR
PROTECTION AGAINST THE DOWNREGULATION OF CHONDROCYTE
ACTIVITY IN OA
K. Yudoh, R. Karasawa, N. Yui. St. Marianna Univ. Sch. of Med., Kawasaki
City, Japan
Purpose: During the development of osteoarthritis (OA), mechanical
and chemical stresses on articular cartilage change the stable cellular
activities of chondrocytes and produce excess amounts of reactive
oxygen species (ROS) as well as proinﬂammatory cytokines and che-
mokines. Previous studies have provided ample conﬁrmation of the
generation of ROS and the depletion of cellular antioxidants in degen-
erated articular cartilage.
An oxidized form of guanine, 8-oxo-7,8-dihydroxyguanine (8-oxo-
guanine), is a major causative lesion for mutagenesis by ROS, because
it can cause a stable base pair with adenine or cytosine during DNA
replication. These mutations are thought to be involved in the path-
ogenesis of a variety of diseases, including degenerative diseases. In
our previous study, we have found that 8-oxoguamine level was
increased in the degenerated articular cartilage in OA, suggesting that
the oxidative damage may accumulate in the OA cartilage. 8-oxogua-
nine DNA glycosylase (Ogg1) repairs 8-oxoguanine, one of the most
abundant DNA adducts caused by oxygen free radicals. We postulated
that depletion of cellular antioxidant, Ogg1, in degenerated articular
cartilage participates in the development of cartilage degeneration.
The aim of the study was examined the potential involvement of
accumulation of 8-Oxoguanine and impairment of mitochondrial DNA
repair enzyme Ogg1 in the pathogenesis of OA.
Methods: The expressions of 8-oxoguanine and Ogg1 were immuno-
histologically investigated in articular cartilage samples from patients
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catabolic factors inﬂuenced the expressions of Ogg1 and 8-oxoguanine
in OA chondrocytes and analysed the relationships among cellular
functions, apoptosis and Ogg1 or 8-oxoguanine expression in human
chondrocytes.
Results: Increased levels of 8-oxoguanine and decreased levels of Ogg1
were observed in OA chondrocytes compared with normal chon-
drocytes in OA rabbits as well as patients with OA. Decreased expression
of Ogg1, but increased expression of 8-oxoguanine, were observed in
chondrocytes treated with OA-related catabolic factors. Ogg1 silencing
using short hairpin RNAs reduced the chondrocyte activity and
augmented chondrocyte apoptosis.
Conclusions: Accumulation of 8-oxoguanine, an oxidized form of
guanine, and downregulation of its repair enzyme Ogg1 in degenerated
articular cartilage may be involved in the pathogenesis of OA. Our
ﬁndings suggest that Ogg1 protects against catabolic stress-induced
chondrocyte dysfunction and apoptosis in OA.Ă
Ă
Fig. 3. Ex vivo experiment. Organ culture of tibiae of mouse embryo (E17.5).Ă
Fig.4. In vivo experiment using Rat OA model. Intraarticular administalation of
DrugX.204
DRUG SCREENING FOR TREATING OSTEOARTHRITIS THROUGH
REGULATION OF WNT SIGNALING
A. Takamatsu y, B. Ohkawara z, T. Sakai y, K. Ohno z,
N. Ishiguro y. yOrthopaedic Surgery, Nagoya Univ. Graduate Schoool of
Med., Nagoya, Japan; zNeurogenetics and Bioinfomatics, Nagoya Univ.
Graduate Schoool of Med., Nagoya, Japan
Purpose: The purposes of this study is to establish a novel therapeutic
strategy for treating osteoarthritis(OA) through regulation of Wnt/b-
catenin signaling.
Methods: Promoter assay: We used a cell-based promoter assay to
screen for chemical activator of FRZB, a soluble antagonist of the Wnt
signaling pathway. This assay utilized Human chondrosarcoma cell co-
transfected with ﬁreﬂy luciferase reporter vector including FRZB
promoter region and Renilla luciferase control vector. We performed
dual screening by combination with TOPFLASH reporter vector that
measures activation of Wnt/b-catenin signaling to ﬁnd drugs activating
FRZB and inhibiting Wnt/b-catenin signaling.
Quantitative RT-PCR & Western blotting: Human articular cartilage
(HAC) was obtained from patients who underwent joint replacement
for knee OA, samples were incubated with DrugX. We quantiﬁed mRNA
levels of chodrogenic markers using realtime RT-PCR and evaluated
protein level of b-catenin by western blotting.
Alcian blue staining: Chondrogenically differentiated ATDC5 were
treated with Wnt3A alone or in the presence of DrugX. After staining
with Alcian blue, the optical density of the extracted dye was measured
using spectrometer.
Organ culture:Mouse embryonic tibiae were cultured with drugX. The
tibial proximal growth plates were either stained with HE and alcian
blue or immunostained with b-catenin antibody.
In vivo surgery and histologic evaluation of OA: We performed rat
DMM surgery for OA model and DrugX was administrated intra-
articularly in right knee. Contralateral kneewas sham-operated. Sagittal
sections were stained with SafraninO and fastgreen and analyzed using
Modiﬁed Mankin Score. Results
We identiﬁed that drugX activated FRZB promoter and inhibitedWnt/b-
catenin signaling in HAC (Fig.1)
Quantitative RT-PCR analyses demonstrated that DrugX upregulated
mRNA levels of FRZB and AGCN, Col2a1, SOX9 dose-dependently, and
inhibited Wnt3A-induced AXIN2 expression (Fig.2)
Western blotting revealed that DrugX decreased the amount of b-cat-
enin protein dose-dependently in HAC (Fig.2)
Alcian Blue staining showed DrugX rescued Wnt3A-inhibited staining
in differentiated ATDC5 (data not shown).Histological analysis of mouse
embryo showed that DrugX diminished the number of hypertrophic
chondrocytes in growth plate. Immunoﬂuoroscene with b-catenin
antibody revealed that DrugX inhibited accumulations of b-catenin in
growth plate (Fig.3).
Analysis of rat OA model showed that DrugX treatment reduced 36% of
cartilage degradation score comparing to that with vehicle treatment at
8 weeks after OA-induced (Fig.4).
Conclusions: We found that DrugX is a novel inhibitor of Wnt/b-cat-
enin signaling in human chondrocytes. Our ﬁndings may open new
avenues for therapeutic intervention in OA.
